Home/Filings/4/0001415889-23-004257
4//SEC Filing

Murray Christopher K. 4

Accession 0001415889-23-004257

CIK 0001597264other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:00 PM ET

Size

14.8 KB

Accession

0001415889-23-004257

Insider Transaction Report

Form 4
Period: 2023-03-01
Murray Christopher K.
SVP, Technical Operations
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-01+17,50017,500 total
    Exercise: $43.15Exp: 2033-03-01Common Stock (17,500 underlying)
  • Award

    Common Stock

    2023-03-01+8,75027,570 total
Footnotes (2)
  • [F1]The reported transaction involved the Reporting Person's receipt of grant of 8,750 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
  • [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2023 and as to an additional 1/48th of the shares underlying the option each month thereafter.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1
  • filerCIK 0001718648

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
14.8 KB